Financhill
Back

Bechtle AG Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
38

BECTY
Bechtle AG

Last Price:
$6.84
Seasonality Move:
-5.11%
Sell
40

SRPT
Sarepta Therapeutics

Last Price:
$107.18
Seasonality Move:
1.75%
Sell
38
Bechtle AG (BECTY) is a Sell

Is Bechtle AG a Buy, Sell or Hold?

  • The current Bechtle AG [BECTY] share price is $6.84. The Score for BECTY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • BECTY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $105.35. The Score for SRPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BECTY Stock Price Chart

What is Bechtle AG's stock price today?

  • The Bechtle AG share price today is $6.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BECTY is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $105.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BECTY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 76.43 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.3 - 6.72) Buy
Bollinger Bands (100): (6.46 - 7.68) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.26 Sell
Relative Strength Index (14 RSI): 30.3 Sell
Chaikin Money Flow: 907164 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.77 - 118.35) Sell
Bollinger Bands (100): (114.01 - 127.71) Sell

BECTY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.8 Buy
20-day SMA: 6.56 Buy
50-day SMA: 6.6 Buy
200-day SMA: 8.05 Sell
8-day EMA: 6.77 Buy
20-day EMA: 6.64 Buy
50-day EMA: 6.71 Buy
200-day EMA: 7.77 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.87 Sell
20-day SMA: 113.62 Sell
50-day SMA: 119.39 Sell
200-day SMA: 128.44 Sell
8-day EMA: 109.65 Sell
20-day EMA: 113.1 Sell
50-day EMA: 117.33 Sell
200-day EMA: 123.21 Sell

Bechtle AG Earnings Growth & BECTY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Bechtle AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):